LIQUID-CHROMATOGRAPHIC DETERMINATION OF AMIODARONE AND ITS DESETHYL METABOLITE IN PLASMA

被引：0
作者：
SHIPE, JR
机构：
来源：
CLINICAL CHEMISTRY | 1984年 / 30卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1259 / 1259
页数：1
相关论文
共 10 条
  • [1] ANASTASIOUNANA M, 1982, INT J CLIN PHARM TH, V20, P524
  • [2] NEW, ACCURATE SEMI-AUTOMATIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR ROUTINE MONITORING OF AMIODARONE PLASMA-LEVELS
    DURANTI, L
    CARACCIOLO, M
    ORIANI, G
    [J]. JOURNAL OF CHROMATOGRAPHY, 1983, 277 (OCT): : 401 - 407
  • [3] CLINICAL PHARMACOKINETICS AND EFFICACY OF AMIODARONE FOR REFRACTORY TACHYARRHYTHMIAS
    HAFFAJEE, CI
    LOVE, JC
    CANADA, AT
    LESKO, LJ
    ASDOURIAN, G
    ALPERT, JS
    [J]. CIRCULATION, 1983, 67 (06) : 1347 - 1355
  • [4] RELATIONSHIPS BETWEEN AMIODARONE DOSAGE, DRUG CONCENTRATIONS, AND ADVERSE SIDE-EFFECTS
    HEGER, JJ
    PRYSTOWSKY, EN
    ZIPES, DP
    [J]. AMERICAN HEART JOURNAL, 1983, 106 (04) : 931 - 935
  • [5] HIGH-PRESSURE LIQUID-CHROMATOGRAPHY OF AMIODARONE IN BIOLOGICAL-FLUIDS
    LESKO, LJ
    MARION, A
    CANADA, AT
    HAFFAJEE, C
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (12) : 1366 - 1368
  • [6] DRUG-INTERACTIONS WITH AMIODARONE
    MARCUS, FI
    [J]. AMERICAN HEART JOURNAL, 1983, 106 (04) : 924 - 930
  • [7] ADVERSE REACTIONS DURING TREATMENT WITH AMIODARONE HYDROCHLORIDE
    MCGOVERN, B
    GARAN, H
    KELLY, E
    RUSKIN, JN
    [J]. BRITISH MEDICAL JOURNAL, 1983, 287 (6386) : 175 - 180
  • [8] DETERMINATION OF AMIODARONE AND ITS N-DEETHYLATED METABOLITE IN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    MOSTOW, ND
    NOON, DL
    MYERS, CM
    RAKITA, L
    BLUMER, JL
    [J]. JOURNAL OF CHROMATOGRAPHY, 1983, 277 (OCT): : 229 - 237
  • [9] SOLOW EB, 1983, CLIN CHEM, V29, P1204
  • [10] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC MEASUREMENT OF AMIODARONE AND ITS DESETHYL METABOLITE - METHODOLOGY AND PRELIMINARY-OBSERVATIONS
    STOREY, GCA
    HOLT, DW
    HOLT, P
    CURRY, PVL
    [J]. THERAPEUTIC DRUG MONITORING, 1982, 4 (04) : 385 - 388
1